Completed PHASE1 INTERVENTIONAL 1-arm NCT01909154

Safety Study of Local Administration of Autologous Bone Marrow Stromal Cells in Chronic Paraplegia (CME-LEM1)

Phase I Pilot Study to Evaluate the Security of Local Administration of Autologous Stem Cells Obtained From the Bone Marrow Stroma, in Traumatic Injuries of the Spinal Cord

Sponsor: Puerta de Hierro University Hospital

Conditions Spinal Cord Injury

Interventions Mesenchymal stromal cell therapy

Updated 8 times since 2017 Last updated: Mar 28, 2019 Started: Mar 31, 2013 Primary completion: Apr 30, 2014 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01909154, this PHASE1 trial focuses on Spinal Cord Injury and remains completed. Sponsored by Puerta de Hierro University Hospital, it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Apr 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Apr 2019 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Puerta de Hierro University Hospital

Data source: Puerta de Hierro University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Majadahonda, Spain